Cidara Therapeutics, Inc is a biotechnology business based in the US. Cidara Therapeutics shares (CDTX) are listed on the NASDAQ and all prices are listed in US Dollars. Cidara Therapeutics employs 79 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Cidara Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CDTX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Cidara Therapeutics stock price (NASDAQ: CDTX)Use our graph to track the performance of CDTX stocks over time.
Cidara Therapeutics shares at a glance
|Latest market close||$2.02|
|52-week range||$1.46 - $4.34|
|50-day moving average||$1.95|
|200-day moving average||$2.24|
|Wall St. target price||$6.67|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.14|
Buy Cidara Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Cidara Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cidara Therapeutics price performance over time
|1 week (2021-07-15)||N/A|
|1 month (2021-06-25)||1.51%|
|3 months (2021-04-26)||-11.01%|
|6 months (2021-01-22)||N/A|
|1 year (2020-07-22)||N/A|
|2 years (2019-07-22)||N/A|
|3 years (2018-07-22)||N/A|
|5 years (2016-07-22)||N/A|
Cidara Therapeutics financials
|Revenue TTM||$11.9 million|
|Gross profit TTM||$-55,950,000|
|Return on assets TTM||-68.25%|
|Return on equity TTM||-262.75%|
|Market capitalisation||$74.8 million|
TTM: trailing 12 months
Shorting Cidara Therapeutics shares
There are currently 954,446 Cidara Therapeutics shares held short by investors – that's known as Cidara Therapeutics's "short interest". This figure is 40.7% down from 1.6 million last month.
There are a few different ways that this level of interest in shorting Cidara Therapeutics shares can be evaluated.
Cidara Therapeutics's "short interest ratio" (SIR)
Cidara Therapeutics's "short interest ratio" (SIR) is the quantity of Cidara Therapeutics shares currently shorted divided by the average quantity of Cidara Therapeutics shares traded daily (recently around 518720.65217391). Cidara Therapeutics's SIR currently stands at 1.84. In other words for every 100,000 Cidara Therapeutics shares traded daily on the market, roughly 1840 shares are currently held short.
However Cidara Therapeutics's short interest can also be evaluated against the total number of Cidara Therapeutics shares, or, against the total number of tradable Cidara Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cidara Therapeutics's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Cidara Therapeutics shares in existence, roughly 20 shares are currently held short) or 0.0269% of the tradable shares (for every 100,000 tradable Cidara Therapeutics shares, roughly 27 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Cidara Therapeutics.
Find out more about how you can short Cidara Therapeutics stock.
Cidara Therapeutics share dividends
We're not expecting Cidara Therapeutics to pay a dividend over the next 12 months.
Cidara Therapeutics share price volatility
Over the last 12 months, Cidara Therapeutics's shares have ranged in value from as little as $1.46 up to $4.34. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cidara Therapeutics's is 1.3346. This would suggest that Cidara Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Cidara Therapeutics overview
Cidara Therapeutics, Inc. , a biotechnology company, focuses on the discovery, development, and commercialization of novel long-acting anti-infectives for the treatment and prevention of diseases in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of serious invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop antiviral conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-CoV-2 strains causing COVID-19. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014.
Stocks similar to Cidara Therapeutics
Cidara Therapeutics in the news
Cidara Therapeutics: Rezafungin Data Could Bring Value
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
Cidara Therapeutics Presents New Analyses from Multiple Rezafungin Studies at ECCMID 2021
Frequently asked questionsWhat percentage of Cidara Therapeutics is owned by insiders or institutions?
Currently 8.845% of Cidara Therapeutics shares are held by insiders and 46.472% by institutions. How many people work for Cidara Therapeutics?
Latest data suggests 79 work at Cidara Therapeutics. When does the fiscal year end for Cidara Therapeutics?
Cidara Therapeutics's fiscal year ends in December. Where is Cidara Therapeutics based?
Cidara Therapeutics's address is: 6310 Nancy Ridge Drive, San Diego, CA, United States, 92121 What is Cidara Therapeutics's ISIN number?
Cidara Therapeutics's international securities identification number is: US1717571079 What is Cidara Therapeutics's CUSIP number?
Cidara Therapeutics's Committee on Uniform Securities Identification Procedures number is: 171757107
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert